B-cell lymphomas

October 30, 2018

BTK Inhibitor M7583 Shows Significant Benefit in B-Cell Lymphomas in Phase 1 Trial

News

Bruton’s tyrosine kinase (BTK) inhibitor M7583 is proving to be safe and beneficial in patients with refractory or resistant B-cell lymphomas, according to an ongoing Phase 1 trial. Updated trial data ... Read more

October 13, 2017

Four Patients Complete Treatment in Phase 2 Trial of OXS-1550 as Lymphoma and Leukemia Treatment

News

Four lymphoma and leukemia patients have completed treatment with the cancer therapy OXS-1550 (DT2219ARL) in a Phase 2 clinical trial being run by GT Biopharma and the University of Minnesota. ... Read more

October 6, 2017October 6, 2017

CCRM and Affigen Partner to Develop Personalized Therapeutics for B-Cell Lymphoma, Leukemia

News

CCRM, a Canadian nonprofit that develops regenerative medicine technologies, and Affigen will collaborate on the development and commercialization of a closed platform that produces targeted therapies personalized for a patient’s ... Read more

June 29, 2017

What Are the Different Types of Lymphoma in Young People?

Lymphoma is the most common form of cancer in teenagers and young adults. There are two main types of lymphoma that affect people between the ages of 15 and 24: Hodgkin’s lymphoma ... Read more

October 7, 2016October 7, 2016

First B-Cell Lymphoma Patients Dosed in Phase 1 Study of Potential Therapy

News

Dosing of patients has begun in a Phase 1 clinical trial evaluating the safety and tolerability of Karus Therapeutics‘ lead anti-cancer candidate, KA2237, as a treatment for B-cell lymphoma, the company announced. The ... Read more

May 5, 2016May 5, 2016

Compound Effectively Targets Mutated Protein in B-Cell Lymphoma and Melanoma Early Study

News

A new investigational compound targeting a specific protein that is frequently mutated and malfunctioning in lymphoma and melanoma patients has shown promising results in mice cancer models. The study, “An ... Read more

April 22, 2016April 22, 2016

Cyclacel Releases Promising Preclinical Data on Potential B-Cell Lymphoma Drug, Is Enrolling Patients for Phase 1 Study

News

Cyclacel Pharmaceuticals disclosed promising preclinical results of its drug candidate, CYC065, for the treatment of B-cell lymphoma in a poster presentation at the recent American Association for Cancer Research (AACR) annual meeting ... Read more

January 29, 2016March 8, 2016

B-Cell Lymphoma Survivor: Second Opinion Saved My Life

Learn more about B-Cell Lymphoma: http://bit.ly/1mKbh7b

January 25, 2016January 25, 2016

Immunotherapy for Lymphomas Related to EBV Entering Clinical Trial in Canada

News

Health Canada recently approved a Phase I clinical trial of adoptive cellular immunotherapy specific to Epstein-Barr virus (EBV) aimed at treating EBV-associated lymphomas. The technique is an adaptation of methods initially ... Read more